Table II.
Characteristics of colorectal cancer patients.
| Variables | n (%) |
|---|---|
| HE4 | |
| Positive | 13 (28.3) |
| Negative | 33 (71.7) |
| Lymph node status | |
| Positive | 33 (71.7) |
| Negative | 13 (28.3) |
| CEAa | |
| Positive | 28 (66.7) |
| Negative | 14 (33.3) |
| CA199b | |
| Positive | 17 (40.5) |
| Negative | 25 (59.5) |
| Grade | |
| 1 | 13 (35.1) |
| 2 | 21 (56.8) |
| 3 | 3 (8.1) |
| Stage | |
| I | 2 (4.3) |
| II | 11 (23.9) |
| III | 11 (23.9) |
| IV | 22 (47.9) |
a
A CEA level 0–3.4 ng/ml was considered as negative and >3.4 ng/ml as positive
b
a CA199 level 0–37 U/ml was considered as negative and >37 U/ml as positive according to our laboratory cut-off values. HE4, human epididymis protein 4; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19–9.